webinar register page

Webinar banner
The OncoLens Molecular and Rare Disease Tumor Board Monthly Series
Live 60-Minute Webinar
Dates TBD in June

Please join us for our next Molecular Tumor Board on best practices for biomarker testing in breast, non-small cell, and gastric cancer.

The oncology landscape is rapidly evolving, and precision medicine has become a vital area of research. Early targeted therapies focused on just a few genetic mutations and cancer types, but our ever-expanding knowledge of genetic drivers has revealed promising biomarkers across a growing range of tumor lines. The rapid evolution from a one-size-fits-all approach has led to an increased focus on molecular profiling to match genomic alterations with targeted therapies that optimize patient outcomes.

Join us for a Grand Rounds program where important case scenarios will be presented, along with expert guidance on overcoming common testing barriers in the community oncology setting.

Featured Speaker:

Maria E. Arcila, MD
Director, Molecular Diagnostic Laboratory Director
Molecular Hematopathology
Memorial Sloan Kettering Cancer Center


Lijo Simpson, MD
Medical Oncologist and Hematologist
Atlanta Cancer Care
May 7, 2021 01:00 PM
Jun 7, 2021 01:00 PM
Jul 7, 2021 01:00 PM
Aug 7, 2021 01:00 PM
Time shows in
Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Maria E. Arcila, MD
Director, Molecular Diagnostic Laboratory, Director Molecular Hematopathology @Memorial Sloan Kettering Cancer
Dr. Arcila, is an anatomic and clinical pathologist with subspecialty training in molecular genetic pathology and hematopathology. She received her medical degree from the University of Pittsburgh School of Medicine. She completed her fellowship at Memorial Sloan Kettering and her residency at Madigan Army Medical Center. She is board certified in molecular genetic pathology, hematology, and anatomic and clinical pathology. She served as Medical Director of the Blood Bank & Transfusion Services for Kendrick Memorial Blood Center, as well as Chief of the Core Laboratories in the Department of Pathology and Area Lab Services at Eisenhower Army Medical Center. As the laboratory director for Diagnostic Molecular Pathology at Memorial Sloan Kettering, she is directly involved with the expansion, validation, and implementation of new clinical tests to detect genetic alterations that are relevant to the management and treatment of patients with both solid tumors and hematologic malignancies.
Lijo Simpson, MD
Medical Oncologist and Hematologist @Atlanta Cancer Care
Lijo is a board certified Hematologist and Medical Oncologist with Atlanta Cancer Care and practices at DeKalb Medical Center and Southern Regional Medical Center in the Atlanta area. He has been named to the Atlanta Magazine’s list of top doctors from 2013 to 2018. He has published numerous articles outlining his research in colorectal, genitourinary, hematologic cancers and melanoma and has also presented extensively at the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH) and at the American Society of Bone Marrow Transplantation (ASBMT). He is a member of the American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH). He has over six years of research experience as a Principal Investigator and Sub Investigator in numerous Phase two to four trials. Lijo completed his fellowship in Hematology and Medical Oncology from The Mayo Clinic, Rochester MN and his residency from Advocate Illinois Masonic Medical Center, Chicago.